Skip to main content
Year archive

BioSenic SA — 2019 filings

All 135 regulatory filings released by BioSenic SA (BIOS) in 2019, sourced directly from the official regulator.

135 Filings
2019 Period
2019 filings (135)
Filing Released Lang
PR_2019-12-30_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-12-30 English
PR_2019-12-30_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2019-12-30 French
Bone Therapeutics announces the appointment of Dr. Miguel Forte as CEO to lead the Company into the next phase of development
Board/Management Information
2019-12-19 English
Bone Therapeutics annonce la nomination du Dr. Miguel Forte en tant que Directeur Général, afin de mener la Société dans la prochaine phase de Développement
Board/Management Information
2019-12-19 French
20191212_BOTHE_Acte-Notaire.pdf
AGM Information
2019-12-12 French
PR_2019-12-09_BT_Transparency Notification SRIW_EN_Final.pdf
Major Shareholding Notification
2019-12-09 English
PR_2019-12-09_BT_Transparency Notification SRIW_FR_Final.pdf
Major Shareholding Notification
2019-12-09 French
PR_2019-11-29_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-11-29 English
PR_2019-11-29_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-11-29 French
20191212_BOTHE_Convocation AGE.pdf
AGM Information
2019-11-25 French
20191212_BOTHE_Proxy form_ EGM.pdf
Proxy Solicitation & Information Statement
2019-11-25 English
20191212_BOTHE_Procuration_ AGE.pdf
Proxy Solicitation & Information Statement
2019-11-25 French
20191212_BOTHE_Shareholders rights.pdf
AGM Information
2019-11-25 English
20191212_BOTHE_Statutory tables_2019-09-30.pdf
Interim / Quarterly Report 9M 2019
2019-11-25 English
20191212_BOTHE_Convening notice EGM_final.pdf
AGM Information
2019-11-25 English
20191212_BOTHE_Droits actionnaires.pdf
AGM Information
2019-11-25 French
PR_2019-11-25_BT_EGM_2019-12-12_Notice_EN_Final.pdf
AGM Information
2019-11-25 English
PR_2019-11-25_BT_EGM_2019-12-12_Notice_FR_Final.pdf
AGM Information
2019-11-25 French
20191122_BOTHE_Acte-Notaire.pdf
AGM Information
2019-11-22 French
PR_2019-11-06_BT_2019-Q3_EN_Final.pdf
Earnings Release 9M 2019
2019-11-06 English
PR_2019-11-06_BT_2019-Q3_FR_FinaI.pdf
Earnings Release 9M 2019
2019-11-06 French
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 22 novembre 2019
Regulatory Filings
2019-10-22 French
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 22 November 2019 have been made available
AGM Information
2019-10-22 English
20191122_BOTHE_Convening notice EGM_final.pdf
AGM Information
2019-10-22 English
20191122_BOTHE_Procuration_ AGE.pdf
Proxy Solicitation & Information Statement
2019-10-22 French
20191122_BOTHE_Shareholders rights.pdf
AGM Information
2019-10-22 English
20191122_BOTHE_Convocation AGE_Final.pdf
AGM Information
2019-10-22 French
20191122_BOTHE_Proxy form_ EGM.pdf
Proxy Solicitation & Information Statement
2019-10-22 English
20191122_BOTHE_Droits actionnaires.pdf
AGM Information
2019-10-22 French
PR_2019-10-22_BT_EGM3_2019-11-22_Notice_EN_Final.pdf
AGM Information
2019-10-22 English
PR_2019-10-22_BT_EGM3_2019-11-22_Notice_FR_Final.pdf
AGM Information
2019-10-22 French
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
Share Issue/Capital Change
2019-10-03 French
Bone Therapeutics SA: Information on the total number of voting rights and shares
Share Issue/Capital Change
2019-10-03 English
PR_2019-10-03_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-10-03 English
PR_2019-10-03_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2019-10-03 French
Bone Therapeutics présentera des données précliniques sur les propriétés ostéogéniques d’ALLOB dans la régénération osseuse à l’occasion de la 27e réunion annuelle de l’EORS (European Orthopaedic Rese
Regulatory Filings
2019-10-02 French
Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at 27th Annual Meeting of the European Orthopaedic Research Society
Regulatory Filings
2019-10-02 English
Bone Therapeutics to present data from its Phase II/III trial with JTA-004 at the 2nd World Congress on Rheumatology & Orthopedics
Regulatory Filings
2019-09-27 English
Bone Therapeutics présentera les données cliniques de la phase II/III de l’essai évaluant JTA-004 à l’occasion du 2ème Congrès Mondial de Rhumatologie et d’Orthopédie (WCRO)
Regulatory Filings
2019-09-27 French
Bone Therapeutics SA: Information on the total number of voting rights and shares
Share Issue/Capital Change
2019-09-09 English
Bone Therapeutics SA: Information on the total number of voting rights and shares
Share Issue/Capital Change
2019-09-09 English
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
Share Issue/Capital Change
2019-09-09 French
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
Share Issue/Capital Change
2019-09-09 French
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
Share Issue/Capital Change
2019-09-09 French
Bone Therapeutics SA: Information on the total number of voting rights and shares
Share Issue/Capital Change
2019-09-09 English
PR_2019-09-09_BT_CB Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-09-09 English
PR_2019-09-09_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-09-09 French
Bone Therapeutics publie ses résultats du premier semestre 2019
Earnings Release H1 2019
2019-08-30 French
Bone Therapeutics publie ses résultats du premier semestre 2019
Earnings Release H1 2019
2019-08-30 French
Bone Therapeutics publie ses résultats du premier semestre 2019
Earnings Release H1 2019
2019-08-30 French
Bone Therapeutics publie ses résultats du premier semestre 2019
Earnings Release H1 2019
2019-08-30 French
Bone Therapeutics reports half year 2019 results
Earnings Release H1 2019
2019-08-30 English
Bone Therapeutics reports half year 2019 results
Earnings Release H1 2019
2019-08-30 English
Bone Therapeutics reports half year 2019 results
Earnings Release H1 2019
2019-08-30 English
Bone Therapeutics reports half year 2019 results
Earnings Release H1 2019
2019-08-30 English
PR_2019-08-30_BT_2019H1_EN_Final_Long.pdf
Interim / Quarterly Report H1 2019
2019-08-30 English
PR_2019-08-30_BT_2019H1_FR_Final_Long.pdf
Earnings Release H1 2019
2019-08-30 French
20190830_Bone Therapeutics_Interim Financial Report H1 2019_EN_Final.pdf
Interim / Quarterly Report H1 2019
2019-08-30 English
20190830_Bone Therapeutics_Interim Financial Report H1 2019_FR_Final.pdf
Interim / Quarterly Report H1 2019
2019-08-30 French
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
Report Publication Announcement
2019-08-22 French
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
Report Publication Announcement
2019-08-22 French
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
Report Publication Announcement
2019-08-22 French
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
Report Publication Announcement
2019-08-22 French
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
Report Publication Announcement
2019-08-22 French
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Report Publication Announcement
2019-08-22 English
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Report Publication Announcement
2019-08-22 English
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Report Publication Announcement
2019-08-22 English
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Report Publication Announcement
2019-08-22 English
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Report Publication Announcement
2019-08-22 English
PR_2019-07-30_BT_CB Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-07-30 English
PR_2019-07-30_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-07-30 French
PR_2019-07-11_BT_Transparency Notification SRIW_EN_Final.pdf
Major Shareholding Notification
2019-07-11 English
PR_2019-07-11_BT_Transparency Notification SRIW_FR_Final.pdf
Major Shareholding Notification
2019-07-11 French
Notification-Transparence_tr-1be-fr_Reymann-Jacques_2019-07_Signed.PDF
Major Shareholding Notification
2019-07-04 French
PR_2019-07-04_BT_Transparency Notification-JReymann_EN_Final.pdf
Major Shareholding Notification
2019-07-04 English
PR_2019-07-04_BT_Transparency Notification-JReymann_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-07-04 French
PR_2019-07-02_BT_ABB2019 Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-07-02 English
PR_2019-07-02_BT_ABB2019 Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-07-02 French
20190626_Rapport_spécial BoD.pdf
Share Issue/Capital Change
2019-06-27 French
Bone Therapeutics successfully raises EUR 8.5 million
Capital/Financing Update
2019-06-27 English
Bone Therapeutics lève avec succès 8,5 M€
Share Issue/Capital Change
2019-06-27 French
Bone Therapeutics to raise capital through private placement of new shares and issuance of non-dilutive subordinated bonds
Capital/Financing Update
2019-06-27 English
Bone Therapeutics annonce le lancement d'un placement prive et l'émission d'obligations subordonnées non dilutives
Share Issue/Capital Change
2019-06-27 French
PR_2019-06-21_BT_CB Denominator_EN_ Final.pdf
Share Issue/Capital Change
2019-06-21 English
PR_2019-06-21_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-06-21 French
20190612_AGO_PV_signé.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-06-13 French
20190612_AGE2_acte notarié_signé.pdf
AGM Information
2019-06-13 French
ALLOB meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion procedure
Regulatory Filings
2019-06-13 English
ALLOB valide les principaux critères d’évaluation de l’étude de phase IIa chez des patients ayant subi une procédure de fusion vertébrale
Earnings Release Q2 2019
2019-06-13 French
PR_2019-05-29_BT_CB Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-05-29 English
PR_2019-05-29_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2019-05-29 French
20190612_BOTHE_Convening notice EGM_FINAL.pdf
AGM Information
2019-05-24 English
20190612_BOTHE_Convocation AGE_FINAL.pdf
AGM Information
2019-05-24 French
20190612_BOTHE_Proxy form_ EGM_FINAL.pdf
Proxy Solicitation & Information Statement
2019-05-24 English
20190612_BOTHE_Procuration_ AGE_FINAL.pdf
Proxy Solicitation & Information Statement
2019-05-24 French
BT_2019-04-23_AGE_Droits actionnaires_EN.pdf
AGM Information
2019-05-24 English
BT_2019-04-23_AGE_Droits actionnaires_FR.pdf
AGM Information
2019-05-24 French
PR_2019-05-24_BT_EGM2_2019-06-12_Notice_FR_Final.pdf
AGM Information
2019-05-24 French
PR_2019-05-24_BT_EGM2_2019-06-12_Notice_EN_Final.pdf
AGM Information
2019-05-24 English
20190523_BOTHE_PV_ AGE1.pdf
AGM Information
2019-05-24 French
BT_2019-05-10_AGO_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2019-05-10 English
BT_2019-05-10_AGO_CV_Jean-Paul PRIEELS.pdf
Board/Management Information
2019-05-10 English
BT_2019-05-10_AGO_Procuration_FR.pdf
Proxy Solicitation & Information Statement
2019-05-10 French
BT_2019-05-10_AGO_CV_Gloria MATTHEW.pdf
Board/Management Information
2019-05-10 English
BT_2019-05-10_Comptes Annuels 2018.pdf
Interim / Quarterly Report FY 2018
2019-05-10 French
BT_2019-05-10_AGO_CV_Thomas LIENARD.pdf
Board/Management Information
2019-05-10 English
BT_2019-05-10_AGO_Convocation_FR.pdf
AGM Information
2019-05-10 French
BT_2019-05-10_AGO_Convocation_EN.pdf
AGM Information
2019-05-10 English
BT_Auditor Report-Bone Therapeutics SA-31Dec2018.pdf
Audit Report / Information FY 2018
2019-05-10 French
PR_2019-05-10_BT_AGO 2019 Notice_FR_Final.pdf
Report Publication Announcement
2019-05-10 French
PR_2019-05-10_BT_AGO 2019 Notice_EN_Final.pdf
AGM Information
2019-05-10 English
PR_2019-05-07_BT_2019-Q1_EN_Final.pdf
Earnings Release Q1 2019
2019-05-07 English
PR_2019-05-07_BT_2019-Q1_FR_Final.pdf
Earnings Release Q1 2019
2019-05-07 French
PR_2019-04-29_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-04-29 English
PR_2019-04-29_BT_CB Denominator_FR_Final.pdf
Major Shareholding Notification
2019-04-29 French
Annual Report 2018 - Financial Report.pdf
Annual Report FY 2018
2019-04-25 English
Rapport annuel 2018 - Rapport financier.pdf
Annual Report FY 2018
2019-04-25 French
BT_2019-04-23_AGE_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2019-04-23 English
BT_2019-04-23_AGE_Droits actionnaires_FR.pdf
AGM Information
2019-04-23 French
BT_2019-04-23_AGE_Droits actionnaires_EN.pdf
AGM Information
2019-04-23 English
BT_2019-04-23_AGE_Convocation_FR.pdf
AGM Information
2019-04-23 French
BT_2019-04-23_AGE_Convocation_EN.pdf
Proxy Solicitation & Information Statement
2019-04-23 English
BT_2019-04-23_AGE_Procuration_FR.pdf
Proxy Solicitation & Information Statement
2019-04-23 French
PR_2019-04-23_BT_Notice AGE 2019-05-23_EN_Final.pdf
AGM Information
2019-04-23 English
PR_2019-04-23_BT_Notice AGE 2019-05-23_FR_Final.pdf
AGM Information
2019-04-23 French
PR_2019-03-28_BT_CB Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-03-28 English
PR_2019-03-28_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2019-03-28 French
PR_2019-03-05_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-03-05 English
PR_2019-03-05_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2019-03-05 French
PR_2019-03-01_BT_FY2018_EN_Long_Final.pdf
Earnings Release FY 2018
2019-03-01 English
PR_2019-03-01_BT_FY2018_FR_Long_Final.pdf
Earnings Release FY 2018
2019-03-01 French
PR_2019-01-30_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2019-01-30 English
PR_2019-01-30_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2019-01-30 French
Bone Therapeutics announces 2019 business outlook and reports year-end 2018 cash position
Earnings Release FY 2018
2019-01-22 English
Bone Therapeutics annonce ses perspectives d’affaires pour 2019 et dresse son bilan de trésorerie
Earnings Release FY 2018
2019-01-22 French